SCM
STML

Suvretta Capital Management’s Stemline Therapeutics, Inc. STML Stock Holding History

Suvretta Capital Management’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-295,500
Closed -$1.43M – 106
2020
Q1 		$1.43M Buy
+295,500
New +$1.43M 0.04% 44